ES2138956T3 - Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion. - Google Patents

Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion.

Info

Publication number
ES2138956T3
ES2138956T3 ES90110191T ES90110191T ES2138956T3 ES 2138956 T3 ES2138956 T3 ES 2138956T3 ES 90110191 T ES90110191 T ES 90110191T ES 90110191 T ES90110191 T ES 90110191T ES 2138956 T3 ES2138956 T3 ES 2138956T3
Authority
ES
Spain
Prior art keywords
preparation
aza
analogs
imidazoquinoxalinonas
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90110191T
Other languages
English (en)
Inventor
David Daniel Davey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlex Laboratories Inc
Original Assignee
Berlex Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Laboratories Inc filed Critical Berlex Laboratories Inc
Application granted granted Critical
Publication of ES2138956T3 publication Critical patent/ES2138956T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

ESTA INVENCION ES RELATIVA A NUEVAS IMIDOAZOQUINOXALINONAS Y SUS AZO ANALOGOS Y A UN PROCESO PARA SU PREPARACION. LOS COMPUESTOS DE ESTA INVENCION SE HAN DESCUBIERTO PARA TENER EFECTOS FARMACOLOGICOS VASODILATADORES Y OTROS.
ES90110191T 1989-05-31 1990-05-29 Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion. Expired - Lifetime ES2138956T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/359,182 US5055465A (en) 1989-05-31 1989-05-31 Imidazoquinoxalinones, their aza analogs and process for their preparation

Publications (1)

Publication Number Publication Date
ES2138956T3 true ES2138956T3 (es) 2000-02-01

Family

ID=23412679

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90110191T Expired - Lifetime ES2138956T3 (es) 1989-05-31 1990-05-29 Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion.

Country Status (7)

Country Link
US (1) US5055465A (es)
EP (1) EP0400583B1 (es)
AT (1) ATE186728T1 (es)
DE (1) DE69033355T2 (es)
DK (1) DK0400583T3 (es)
ES (1) ES2138956T3 (es)
GR (1) GR3032611T3 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602252A (en) * 1989-11-17 1997-02-11 Berlex Laboratories, Inc. Tricyclic pteridinones and a process for their preparation
US5854419A (en) * 1989-11-17 1998-12-29 Schering Aktiengesellschaft Tricyclic pteridinones and a process for their preparation
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
EP0647137B1 (en) * 1992-06-22 2008-08-13 The Regents Of The University Of California Glycine receptor antagonists and the use thereof
DE4228095A1 (de) * 1992-08-24 1994-03-03 Asta Medica Ag Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
US5306819A (en) * 1992-08-27 1994-04-26 Neurogen Corporation Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
DE4310523A1 (de) * 1993-03-31 1994-10-06 Basf Ag Imidazolo-chinoxalinone zur Behandlung zentralnervöser Erkrankungen
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
IL112235A (en) * 1994-01-03 2000-06-29 Acea Pharm Inc 1,4-dihydro-pyrido¬2,3-b¾pyrazine-2,3-dione (5 or 8) oxide derivatives and pharmaceutical compositions containing them
AU692524B2 (en) * 1994-02-11 1998-06-11 Novo Nordisk A/S Imidazol {1, 2-9} quinoxalinone derivatives and the preparation and use
PL319406A1 (en) * 1994-09-30 1997-08-04 Basf Ag Novel heterocyclically substituted imidazoqunoxalinones, their production and application
US5801183A (en) * 1995-01-27 1998-09-01 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists
DE19510965A1 (de) * 1995-03-24 1996-09-26 Asta Medica Ag Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
DE19611476A1 (de) * 1996-03-22 1997-09-25 Basf Ag Neue heterocyclische substituierte Imidazolo-chinoxalinone, ihre Herstellung und Verwendung
DE19961302A1 (de) * 1999-12-18 2001-06-21 Dresden Arzneimittel Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen
EE200100377A (et) * 1999-01-20 2002-10-15 Arzneimittelwerk Dresden Gmbh Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
JP2002540102A (ja) * 1999-03-22 2002-11-26 ブリストル−マイヤーズ スクイブ カンパニー ｃＧＭＰホスホジエステラーゼの縮合ピリドピリダジン阻害剤
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
US6465465B1 (en) * 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
ES2599054T3 (es) * 2006-12-13 2017-01-31 Aska Pharmaceutical Co., Ltd. Derivados de quinoxalina
US7875618B2 (en) * 2007-11-30 2011-01-25 Wyeth Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders
US20090143361A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10
WO2009068320A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
KR101779137B1 (ko) * 2009-01-23 2017-09-18 다케다 야쿠힌 고교 가부시키가이샤 폴리(ａｄｐ-리보스)폴리머라제(ｐａｒｐ) 억제제
WO2011014681A1 (en) 2009-07-30 2011-02-03 Takeda Pharmaceutical Company Limited Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
JP5822080B2 (ja) * 2010-09-07 2015-11-24 アステラス製薬株式会社 キノキサリン化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138564A (en) * 1977-08-03 1979-02-06 American Home Products Corporation Tetrahydro[1H]pyrazino[1,2-a]azaquinoxalin-5(6H)-ones and derivatives thereof
IL59104A (en) * 1979-02-09 1984-02-29 Roussel Uclaf Heterotricyclic derivatives,process for their preparation and pharmaceutical compositions incorporating them
US4333394A (en) * 1979-12-31 1982-06-08 Brown Stanford M Method for handling and baling metallic scrap material
US4440929A (en) * 1981-07-16 1984-04-03 Usv Pharmaceutical Corporation Imidazoquinoxaline compounds
US4761414A (en) * 1986-08-19 1988-08-02 G. D. Searle & Co. Substituted 1H-pyrimido[1,2-a-]-pyrido[3,4-e]pyrazine 6 oxides

Also Published As

Publication number Publication date
US5055465A (en) 1991-10-08
DK0400583T3 (da) 2000-03-13
DE69033355T2 (de) 2000-05-11
DE69033355D1 (de) 1999-12-23
GR3032611T3 (en) 2000-05-31
EP0400583A1 (en) 1990-12-05
EP0400583B1 (en) 1999-11-17
ATE186728T1 (de) 1999-12-15

Similar Documents

Publication Publication Date Title
ES2138956T3 (es) Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion.
FI914876A0 (fi) Menetelmä peroksidiperfluoripolyeettereiden valmistamiseksi
FI904851A0 (fi) Radiomaerkta antikoagulantpeptider.
ES2022115B3 (es) Procedimiento de produccion de polimeros que contienen amida alcoxilados/modificados cationicamente
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
ES503451A0 (es) Procedimiento para la preparacion de 10-(1,2-propadienil)es-teroides
DE69033069D1 (de) Prostaglandinanaloge
PT87503A (pt) Process for the preparation of new cathecolamine by products
HUT51295A (en) Process for producing peptidalcohol derivatives of anticoagulant activity
DK0433428T3 (da) Hidtil ukendt stabil form af cephradin, fremgangsmåde til fremstilling deraf og mellemprodukter anvendt derved
DK582083A (da) 4,7-dihydropyrazol(3,4-b)pyridin-5-karboxylsyrederivater
PT90212A (pt) Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas
MX9101181A (es) Proceso para la preparacion de compuestos que contienen nitrogeno ciclico
SE8404334L (sv) 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning
DK259486A (da) Fremgangsmaade til fremstilling af 7-aca-derivater
DE3470312D1 (de) Ether of n-propanolamine derivative
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.
FI91069B (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
ES2067621T3 (es) Procedimiento para la preparacion de compuestos molusquicidas de 2,4,5-tribromopirrol-3-carbonitrilo.
GR1000880B (el) Ασυμμετρος συνθεση παραγωγων φουρο (3,4-c) πουριδινης.
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
FI102166B1 (fi) Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi
DE69113871D1 (de) Hypotriglyceridämische Verwendung von Bis(3,5-di-alkyl-4-hydroxyphenylthio)methanen.
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
ATE109773T1 (de) Acylierungsprodukte von 9,10-

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 400583

Country of ref document: ES